Expand JAZZ Menu
JAZZ MENU

JAZZ Stock Posts


Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -229.93+15.49 (+7.2%)

Jazz Pharmaceuticals PLC - trades 2,087 contracts. The highest volume is in the 20-Nov-26 200 puts. News: Jazz Pharmaceuticals Announces Third Quarter 2026 Financial Results
Upcoming Earnings

JAZZ Jazz Pharmaceuticals PLC -215.40-0.58 (-0.3%)

Jazz Pharmaceuticals PLC - will report earnings after the market closes. View Calendar The market is expecting a ±9.2% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.8%. View Expected Move (Conf Call: Nov 2 4:30 PM)
$JAZZ Earnings November 02 AMC. Options Imply ±9.2% Move. Shares lost -17.5% since the last report
Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -212.66+4.83 (+2.3%)

Jazz Pharmaceuticals PLC - trades 4,005 contracts. JAZZ will report earnings on Nov 2, 2026.
Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -214.98+3.01 (+1.4%)

Jazz Pharmaceuticals PLC - trades 2,959 contracts. The highest volume is in the 18-Dec-26 240 calls, which is 11.6% above the current price.
Unusual Option Volume

JAZZ Jazz Pharmaceuticals PLC -264.67+10.20 (+4.0%)

Jazz Pharmaceuticals PLC - trades 2,793 contracts. The company has the following event: on Aug 25, 2026. News: U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Market Data Delayed 15 Minutes